Turning Point Therapeutics Inc (NASDAQ:TPTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carl Gordon Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past) | Director · Apr 16, 2019 – Jun 15, 2020 · Past |
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · May 13, 2019 – Aug 17, 2022 · Past |
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past) | Director · Jul 24, 2019 – Aug 17, 2022 · Past |
| Sheila Gujrathi Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past) | Director · Apr 16, 2019 – Jun 15, 2020 · Past |
| Athena Countouriotis Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Passage Bio, Inc. (Chief Executive Officer and Chairperson of the board of directors of Avenzo Therapeutics · Since at least Feb 27, 2020); Iovance Biotherapeutics, Inc. (Director · Since at least Jun 10, 2019); Cardiff Oncology, Inc. (Director · Sep 14, 2017 – Jun 20, 2019 · Past); Adverum Biotechnologies Inc (SVP, Chief Medical Officer · Jun 19, 2017 – Feb 15, 2018 · Past); Halozyme Therapeutics, Inc. (SVP and Chief Medical Officer · Jan 5, 2015 – Feb 22, 2017 · Past); Ambit Biosciences Corp (Chief Medical Officer · May 15, 2013 – Nov 10, 2014 · Past) | President & CEO, Director · Apr 16, 2019 – Aug 17, 2022 · Past |
| Barbara Bodem Other companies: Option Care Health, Inc. (Director · Since at least Jan 2, 2024); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Enovis Corporation (Director · Since at least Apr 4, 2022); Dentsply Sirona Inc. (Interim CFO · May 6, 2022 – May 6, 2022 · Past); Syneos Health Inc (Director · Jan 15, 2022 – Sep 28, 2023 · Past); Hill-Rom Holdings Inc (SVP, Chief Financial Officer · Dec 3, 2018 – Dec 13, 2021 · Past); Invacare Corporation (Director · Aug 18, 2017 – Mar 16, 2018 · Past) | Director · Mar 31, 2021 – Aug 17, 2022 · Past |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Jun 2, 2021 – Aug 17, 2022 · Past |
| Simeon George Other companies: ADARx Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2026); Design Therapeutics, Inc. (Director · Since at least Jun 15, 2022); CRISPR Therapeutics AG (Director · Since at least Jun 9, 2022); Nkarta, Inc. (Director · Since at least Apr 28, 2022) | Director · Aug 17, 2022 – Aug 17, 2022 · Past |
| Mark J Alles Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past); Celgene Corporation (CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past) | Director · May 24, 2021 – Aug 17, 2022 · Past |
| Mohammad Hirmand Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Medivation Inc (Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past) | EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past |
| Yi Larson Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2021); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past) | EVP & Chief Financial Officer · Aug 26, 2019 – Feb 8, 2021 · Past |
| Andrew John Partridge Other companies: GRAIL, Inc. (Chief Growth Officer · Since at least Jun 1, 2026) | EVP & Chief Commercial Officer · Jul 13, 2020 – Feb 9, 2022 · Past |
| Kyri Van Hoose Other companies: Dermata Therapeutics, Inc. (Senior Vice President, Chief Financial Officer · Since at least Sep 1, 2021) | Principal Accounting Officer · May 14, 2021 – May 14, 2021 · Past |
| Steve M Sabus Other companies: Syndax Pharmaceuticals, Inc. (Chief Commercial Officer · Dec 5, 2022 – Dec 5, 2022 · Past) | SVP & Chief Commercial Officer · May 31, 2022 – Aug 17, 2022 · Past |
| Yishan Li Other companies: BlossomHill Therapeutics, Inc. (Executive Chairman, Director · Since at least Aug 6, 2026) | Director · Apr 16, 2019 – Apr 16, 2019 · Past |
| Annette North | EVP & General Counsel · Apr 16, 2019 – Feb 9, 2022 · Past |
| Brian Lee Baker | SVP of Finance and Admin. · Apr 16, 2019 – Mar 22, 2021 · Past |
| Brian Sun | SVP & General Counsel · Apr 11, 2022 – Aug 17, 2022 · Past |
| Paolo Tombesi | EVP & Chief Financial Officer · Jul 27, 2022 – Aug 17, 2022 · Past |
| Siegfried Reich | EVP & Chief Scientific Officer · Feb 8, 2021 – Feb 9, 2022 · Past |